Dominique Delbeke, M.D., Ph.D.

Biography
Dominique Delbeke came to America from Belgium having completed her MD, and PhD in Pathology. She was a staff member in Nuclear Medicine until 2000 when Martin Sandler became the Head of the Radiology Department at which time  she became director of the Nuclear Medicine Division. Dominique increased the range of clinical studies using PET along with other diagnostic uses of nuclear medicine procedures. She followed in Sandler as President of the Society of Nuclear Medicine, and shortly thereafter became Editor of the Journal of Nuclear Medicine and Molecular Imaging. Molecular Imaging was added to name of the Journal in response to the growing importance of targeting molecular, cell-based receptors, dell-based markers in diagnosis and therapy. The clinical staff includes a number of physicians and scientists.  William Martin practiced as an Endocrinologist prior to coming to Vanderbilt in 1993 where he completed the residency program, and stayed on the faculty rising rapidly to the rank of Professor.  Ron Walker is a nuclear medicine physician who came to Vanderbilt in 2006 from the University of Arkansas. Gary Smith was trained in Engineering, and Nuclear Medicine and came to Vanderbilt and the VA in 2009 from Knoxville where he was Head of the UT Memorial Hospital Nuclear Medicine program. Chiraya Shah is a Vanderbilt trained radiologist with Nuclear Medicine certification. During his training he spent a year working in VUIIS gaining additional research experience.

CURRICULUM VITAE

Professor and Director of Nuclear Medicine and Positron Emission Tomography

Department of Radiology and Radiological Sciences, Division of Nuclear Medicine  Vanderbilt University Medical Center

EDUCATION AND TRAINING

1971-1978     Free University of Brussels, Belgium  M.D., Ph.D.

1978-1979    Resident in Clinical Pathology

Laboratory of Clinical Chemistry, Hospital St-Pierre

Free University of Brussels, Brussels, Belgium

1979-1982        Resident in Clinical Pathology

Department of Clinical Pathology, Hospital Erasme

Free University of Brussels, Brussels, Belgium

1974-1982               Researcher (part-time) Institute de Recherche Interdisciplinaire  Pr. JE Dumont, Supervisor

Free University of Brussels, Brussels, Belgium

1982-1984                 Postdoctoral Associate

Department of Pharmacology Supervisor: Pr. PS Dannies

Yale University School of Medicine, New Haven, CT 06510

1984-1985                 Clinical Fellow in Pathology

Department of Clinical Pathology

Yale New Haven Hospital, New Haven, CT 06510

 

1985-1986                 Resident in Pathology

Department of Anatomical Pathology

Program Director: Dr. Juan Rosai

Yale New Haven Hospital, New Haven, CT 06510

1986-1988       Resident in Nuclear Medicine  Vanderbilt Department of   Radiology  Program Director: Dr. Martin P. Sandler

1988-1990        Resident in Pathology  Department of Pathology

CERTIFICATION

M.D.  June 1978       Graduate in Medicine, with “Cum Laude,” Free University of Brussels,  Brussels, Belgium

Ph.D. in Physiology April 1985   Free University of Brussels,

Specialty Board

1982      Clinical Pathology: Free University of Brussels, Belgium

1982      Subspecialty Board in In Vitro Nuclear Medicine: Free University of Brussels,      Belgium

1988          American Board of Nuclear Medicine (Certificate # 5302)

1989         American Board of Pathology (Clinical and Anatomical, certificate # 89147)

2008-2009                   SNM: Vice President Elect

2009-2010                   SNM: President Elect

2010-2011                   SNM: President

2011-2012                   SNM: Immediate Past-President

2011-present            SNM: Member of the Committee on Publications

2006-2012                 ERF (Education and Research Foundation): Board of Directors

PUBLICATIONS

  1. Swillens S. Van Sande J, Pochet R, Delbeke D, Piccart M, Paiva M, Dumont JE.Kinetics of adenosine 3′,5′-monophosphate accumulation in dog thyroid slices. Europ J of Biochem 1976;62:87-93.
  2. Jeanty P, Delbeke D, Lemli L, Dorchy H. Smith-Lemli-Opitz syndrome without failure to thrive. Acta Paediatr Belgica 1977;30:175-178
  3. Jeanty P, Delbeke D, Struyven J. Thick walled gallbladder and hypoalbuminemia. Radiology 1981;139:239.
  4. Jeanty P, Dramaix-Wilmet M, Delbeke D, Rodesch F, Struyven J.Ultrasonic evaluation of fetal ventricular growth. Neuro-Radiology 1981;21:123-131.
  5. Delbeke D, Van Sande J, Swillens S, Erneux C, Dumont JE. Cooling enhance adenosine 3′,5′-monophosphate accumulation in thyrotropin stimulated dog thyroid slices. Metabolism 1982;31:797-804.
  6. Delbeke D, Lejeune-Lenain C. Simultaneous RIA measurement of testosterone (T) and dihydrotestosterone (DHT) without chromatography. Annales de Biologie Clinique 1982;40:579-584.
  7. Labroo VM, Kirk KL, Cohen LA, Delbeke D, Dannies PS. Synthesis and biological activity of 5-fluoroimidazole-TRH. Biochem Biophys Res Comm 1983;113(2):581-585.
  8. Van Regemoorter N, Defleur V, Delbeke D, Vamos E, Rodesch F. Alphafeto-protein (aFP), concanavalin A, non reactive aFP and specific acetylcholinesterase in amniotic fluid from pathological pregnancies: Predictive values for open spina bifida. Europ J Obstet Gynecol Reprod Biol 1983;16:9-18.
  9. Delbeke D, Van Sande J, Cochaux P, Decoster C, Dumont JE. Effect of thyrotropin-releasing hormone in dog thyroid in vitro. Biochem Biophys Acta 1983;761:262-268.
  10. Delbeke D, Scammell JG, Dannies PS. Difference in calcium requirements for forskolin-induced release of PRL from normal and GH pituitary cells in culture. Endocrinology 1984;114:1433-1440.
  11. Jeanty P, Rodesch F, Delbeke D, Dumont JE. Estimation of gestational age by measurements of fetal long bones. J Ultr Med 1984;3:75-79.
  12. Delbeke D, Kojima I, Dannies PS, Rasmussen H. Synergistic stimulation of prolactin release by phorbolester, A23187 and forskolin. Biochem Biophys Res Commun 1984;123(2):735-741.
  13. Delbeke D, Dannies PS. Stimulation of the cyclic AMP and the Ca++ messenger systems together reverse dopaminergic inhibition of prolactin release. Endocrinology 1985;117:439-446.
  14. Rasmussen H, Kojima I, Kojima K, Zawalich W, Forder J, Barrett P, Kreutter D, Apfeldorf W, Park S, Caldwell A, Delbeke D, Dannies PS. The calcium messenger system. Satellite Symposium to the Ninth International Congress of Pharmacology, Suppl Clinical Physiol Biochem 1985.
  15. Delbeke D, Kojima I, Dannies PS. Comparison of the patterns of prolactin release in GH4C1 cells and primary pituitary cultures. Moll Cell Endocrinol 1985;43:15-22.
  16. Delbeke D, Scammell JG, Martinez-Campos A, Dannies PS. Dopamine inhibits prolactin release when cyclic AMP levels are elevated. Endocrinology 1986;118:1271-1277.
  17. Delbeke D, Sandler MP, Shaff MI, Miller SF. Cat-scratch disease: Report of a case with liver lesions and no lymphadenopathy. J Nucl Med 1988;29(8):1454-1457.
  18. Delbeke D, Habibian MR. Non inflammatory entities in the differential diagnosis of positive three phase bone imaging. Clin Nucl Med 1988;13:844-851.
  19. Garty I, Delbeke D, Sandler MP. Correlative pediatric imaging. J Nucl Med 1989;30(1):15-24.
  20. Delbeke D, Sachs GA, Sandler MP. Diagnosis of allograft vein thrombosis: Report of a case. Clin Nucl Med 1989;14(8):415-420.
  21. Delbeke D, Powers TA, Sandler MP. Correlative imaging in evaluation of the spine. Clin Nucl Med 1989;14:742-749.
  22. Delbeke D, Frexes-Steed M. The “fading” Meckel diverticulum, an unusual scintigraphic presentation. Clin Nucl Med 1992;17:701-704.
  23. Moody EB, Glassman SB, Hansen AV, Lawrence SK, Delbeke D. Nuclear Medicine cases of the day-Questions. AJR 1992;158 (4):913-914.
  24. Moody EB, Glassman SB, Hansen AV, Lawrence SK, Delbeke D. Nuclear Medicine cases of the day-Answers. AJR 1992;158(6):1382-1386.
  25. Delbeke D, Lorenz CH, Silveira ST, Frist WH, Atkinson JB, Votaw JR, Kessler RM, Sandler MP. N-13-ammonia PET estimation of left ventricular mass and infarct size based on pathological correlation of explanted human hearts. J Nucl Med 1993;34:826-833.
  26. Lawrence S, Van Buren DH, McDonnell Jr RC, Delbeke D. Carcinoma in a transplant kidney detected with MAG3 J Nucl Med 1993;34:2185-2187.
  27. Erb RE, Delbeke D, Sandler MP, Falke THM. Magnetic resonance imaging of Carney’s triad. Southern Medical Journal 1994;87:951-955.
  28. Sandler MP, Delbeke D, Knight SB, Martin WH, Patton JA. The solitary pulmonary nodule: Multimodality comparison between CT/PET/SPECT. Diagn Oncol 1994;4:177.
  29. Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Kessler RM. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995;195:47-52.
  30. Zhao XM, Delbeke D, Sandler MP, Yeoh TK, Votaw JR, Frist WH. N-13-Ammonia and PET to detect allograft coronary artery disease after heart transplantation: comparison with coronary arteriography. J Nucl Med 1995;36:982-987.
  31. Martin WH, Delbeke D, Patton JA, Hendrix B, Weinfeld Z, Ohana I, Kessler RM, Sandler MP. 18FDG-SPECT: Clinical utility and correlation with 18FDG-PET. J Nucl Med 1995;36:988-995.S
  32. Sandler MP, Videlefsky SW, Delbeke D, Patton JA, Meyerowitz C, Martin WH, Ohana I. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with luorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous- acquisition single-photon emission computed tomography. J Am Coll Cardiol 1995;26:870-878.
  33. Delbeke D, Videlefsky SW, Patton JA, Campbell MG, Martin WH, Ohana I, Sandler MP. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with Technetium-99m-MIBI and fluorine-18-FDG. J Nucl Med 1995;36:2110-2119.
  34. Vitola JV, Delbeke D, Sandler MP, Campbell MG, Powers TA, Wright K, Chapman W, Pinson CW. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996;171:21-26.
  35. Martin WH, Delbeke D, Patton JA, Sandler MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Radiology 1996;198:225-231.
  36. Knight SB, Delbeke D, Stewart JR, Sandler MP. Evaluation of pulmonary lesions with FDG PET: comparison of findings in patients with and without a history of prior malignancy. Chest 1996; 109:982-988.
  37. Delbeke D, Lawrence SK, Abou-Khalil BW, Blumenkopf B, Kessler RM. Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on PET-FDG. Investigative Radiology 1996;31:261-266.
  38. Vitola JV, Delbeke D, Meranze S, Mazer M, Pinson CW. Positron emission tomography with 18FDG to evaluate the results of hepatic chemoembolization. Cancer 1996;78:2216-2222.
  39. Anthony LB, Martin WH, Delbeke D, Sandler MP. Somatostatin receptor imaging: predictive and prognostic considerations. Digestion 1996;57 (Suppl 1):50-53.
  40. Lomis KD, Vitola JV, Delbeke D, Snodgrass SL, Chapman WC, Wright JK, Pinson CW. Recurrent gallbladder carcinima at laparoscopy port sites diagnosed by PET scan: Implications for primary and radical second operations. The American Surgeon 1997;63:341-345.
  41. Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright JK, Chapman WC, Pinson CW. Staging recurrent metastatic colorectal carcinoma with positron emission tomography. J Nucl Med 1997;38:1196-1201.
  42. Martin WH, Jones RC, Delbeke D, Sandler MP. A simplified intravenous glucose loading protocol for 18-FDG cardiac single-photon emission tomography. Europ J Nucl Med 1997;24: 1291-1297.
  43. Lowe VL, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, Karis J, Hubner K, Delbeke D, Heiberg EV, Patz EF, Coleman RE. Prospective investigation of PET in lung nodules (PIOPLIN). J Clin Oncol 1998;16:1075-1084.
  44. Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK, Pinson CW. Evaluation of benign versus malignant hepatic lesions with positron emission tomography (PET). Archiv Surg 1998;138:510-516.
  45. Rose AT, Rose DM, Pinson CW, Wright JK, Blair T, Blanke C, Delbeke D, Debelak JP, Chapman WC. Hepatocellular carcinoma outcome based on indicated treatment strategy. The American Surgeon 1998;64:1122-1135.
  46. Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW, Leach SD. 18Fluorodeoxyglucose – positron emission tomography (18FDG – PET) in the management of patients with suspected pancreatic cancer. Annals of Surg 1998;229:729-738.
  47. Delbeke D, Patton JA, Martin WH, Sandler MP. FDG PET and dual-head gamma camera positron coincidence detection imaging using a dual head gamma camera of suspected malignancies and brain disorders. J Nucl Med 1999;40:110-117.
  48. Boren EB, Delbeke D, Patton JA, Sandler MP. Comparison of FDG PET and Positron Coincidence Detection Imaging Using a Dual Head Gamma Camera (DHC) with 5/8 inch NaI(Tl) Crystals in patients with Suspected Body Malignancies. Europ J Nucl Med 1999;26:379-387.
  49. Delbeke D. Oncological applications of FDG-PET imaging: Brain tumors, colorectal cancer, lymphoma and melanoma. J Nucl Med 1999;40:591-603.
  50. Delbeke D. Oncological applications of FDG-PET imaging. J Nucl Med 1999;40:1706-1716.
  51. Delbeke D, Rose M, Chapman WC, Pinson CW, Wright JK, Beauchamp DR, Leach S. Optimal interpretation of F-18FDG Imaging of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 1999;40:1784-1792.
  52. Patton JA, Delbeke D, Sandler MP. Image fusion using an integrated dual head coincidence camera with x-ray tube based attenuation maps. J Nucl Med 2000;41:1364-1368.
  53. Golstein RE, Blevins L, Delbeke D, Martin WH. The effect of minimally invasive radioguided parathyroidectomy on efficacy, hospitalization time, and costs in the management of primary hyperparathyropidism. Annals of Surgery 2000;231(5):732-742.
  54. Mertz HR, Sechopoulos P, Delbeke D, Leach SD. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000;52(3):367-371.
  55. Sandler MP, Patton JA, Delbeke D. X-ray, coincidence data merge in functional anatomic mapping. Diagn Imaging (San Franc). 2000 Jun;22(6):73-77, 79.
  56. Delbeke D, Sandler MP. The role of hybrid cameras in oncology. Semin Nucl Med. 2000;20(4):268-280.
  57. Delbeke D, Martin WH, Patton JA, Sandler MP. Value of Iterative reconstruction, attenuation correction, and image fusion for interpretation of FDG images using an integrated dual-head coincidence camera with X-ray based attenuation maps in patients with known or suspected malignancy. Radiology 2001;218:163-171.
  58. Shihabuddin B, Abou-Khalil B, Delbeke D, Fakhoury T. Orbitofrontal epilepsy masquerading as temporal lobe epilepsy- A case report. Seizure 2001;10:134-138.
  59. Grigolon MV, Delbeke D. 18F-fluorodeoxyglucose uptake in bone infarct: Case report. Clin Nucl Med 2001;26:613-614.
  60. Delbeke D, Kovalsky E, Morgan DS, Martin WH, Kinney M, Arrowsmith T, Greer J. 18F-fluorodeoxyglucose imaging with positron emission tomography for initial staging of Hodgkin’s disease and lymphoma. Molecular Imaging and Biology 2001;4:105-114.
  61. Komori T, Delbeke D. Leptomeningeal carcinomastosis and intramedullary spinal cord metastases from lung cancer: Detection with FDG Positron emission tomography. Clin Nucl Med 2001; 26:905-907.
  62. Delbeke D. Instrumentation for FDG imaging: CDET and PET. Medecine Nucleaire 2001;25:303-311.
  63. Delbeke D. PET evaluation of colorectal carcinomas. Medecine Nucleaire 2001;25:325-331.
  64. Millan E, Abou-Khalil B, Delbeke D. Frontal localization of absence seizures demonstrated by ictal positron emission tomography. Epilepsy Behav 2001;2:54-60.
  65. Komori T, Martin WH, Graber AL, Delbeke D. Serendipitous detection of Cushing’s disease by FDG PET and review of the literature. Clin Nucl Med 2002, 3:176-178.
  66. Vitola JV, Delbeke D. Positron Emission Tomography for evaluation of colorectal carcinoma. Semin Roentgenol 2002; 37:118-128.
  67. Ludwig V, Rice MH, Martin WH, Kelley MC, Delbeke D. PDG-PET uptake in a giant myelolipoma. Molecular Imaging and Biology 2002;4:355-358.
  68. Wudel LJ, Delbeke D, Morris D, Rice MH, Washington MK, Pinson CW, Chapman WC. The role of FDG-PET imaging in the evaluation of hepatocellular carcinoma. Amer Surg 2003;69:117-126.
  69. Ludwig V, Fordice S, Lamar R, Martin WH, Delbeke D. Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG PET and bone scintigraphy. Clin Nucl Med 2003:28:176-179.
  70. Ludwig V, Hopper OW, Martin WH, Kikkawa R, Delbeke D. FDG-PET surveillance of hepatic metastases from prostate cancer following radiofrequency ablation-Case report. . Americ Surg 2003; 69:593-598.
  71. Ludwig V, Martin WH, Delbeke D. Calcium channel beta-blockers: A potential cause of false positive captopril renography. Clin Nucl Med 2003;28:108-112.
  72. Ludwig, V, Komori T, Kolb DC, Martin WH, Sandler MP, Delbeke D. Cerebral lesions incidentally detected on FDG PET images of patients evaluated for body malignancies. Molecular Imaging and Biology 2002; 4(5):359-362.
  73. Delbeke D, Pinson CW. 11C-acetate: A new tracer for the evaluation of hepatocellular carcinoma. J Nucl Med 2003;44:222-223.
  74. Bacharach SL, Bax JJ, Case J, Delbeke D, Martin WH, Patterson RE. PET myocardial glucose metabolism and perfusion imaging with 18FDG, 13NH3 and 82Rb. Part 1-Guidelines for data acquisition and patient preparation. J Nucl Cardiol 2003;10 (5):543-556..
  75. Delbeke D. Pancreatic tumors: Role of imaging in the diagnosis, staging, decision making and treatment. J Hepato-Biliary-Pancreatic Surg 2004;11 (1):4-10.
  76. Lavely WC, Delbeke D, Price RR, Greer JP, Morgan DS, Hallahan DE. FDG PET in decision-making for additional therapy after first-line chemotherapy in patients with newly diagnosed lymphoma. Int J Radiat Oncol Biol Phys 2003;57:307-315.
  77. Delbeke D. PET-CT: La modalite d’imagerie du nouveau millenaire et son impact clinique. Medecine Nucleaire Imagerie Fonctionnelle et Metabolique. Medecine Nucleaire : Imagerie Fonctionnelle et Metabolique 2003. (in press).
  78. Delbeke D. Metabolic imaging with FDG : a primer. Cancer J 2004;10 (4):201-213.
  79. Scarfone C, Lavely WC, Cmelak AJ, Delbeke D, Martin WH, Billheimer D, Hallahan DE. Radiotherapy target definition for head and neck cancer using 3-D positron emission tomography (PET) and x-ray CT imaging. J Nucl Med 2004;45(4):543-552.
  80. Anderson CA, Rice MH, Pinson CW, Chapman WC, Ravi RS, Delbeke D. FDG PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J. Gastrointest Surg 2004;8 (1):90-97.
  81. Cunha Pereira Neto C, Roman CD, Johnson M, Jagasia M., Martin WH, Delbeke D. PET-CT Imaging of a Rare Xanthogranulomatous Process: Erdheim-Chester Disease. Mol Imaging Biol. 2004 Jan-Feb;6(1):63-67
  82. Delbeke D. FDG PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med;2004; 34 (July):209-223 .
  83. Scanga D, Martin WH. Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine and neural crest tumors. Clin Nucl Med 2004;29:86-90.
  84. Tharp K, Israel O, Hausmann J, Bettman L, Martin WH, Daitzchman M, Sandler MP, Delbeke D. Impact of 131I-SPECT-CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Europ J Nucl Med 2004;31 (10):1435-1442.
  85. Delbeke D, Martin WH. Update of PET and PET/CT for hepatobiliary and pancreatic malignancies. HPB 2005;7:166-179.
  86. Roman CD, Martin WH, Delbeke D. Incremental value of fusion imaging with integrated PET-CT in oncology. Clin Nucl Med 2005;30 (5):470-477.
  87. Delbeke D. Integrated PET-CT imaging: Implications for evaluation of patients with colorectal carcinoma. Seminars in Colon & Rectal Surgery 2005;16(2):69-81.
  88. Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD, Weinreb JC, Siegel BA, Federle MF, Townsend DW, Berland LL. Intersociety Dialogue on Concurrent PET-CT with an Integrated Imaging System: From the Joint ACR/SNM/SCBT-MR PET-CT Working Group. J Nucl Med 2005;46:1225-1239.
  89. Coleman RE, Delbeke D, Guiberteau MJ, Conti PS, Royal HD, Weinreb JC, Siegel BA, Federle MF, Townsend DW, Berland LL. Intersociety Dialogue on Concurrent PET-CT with an Integrated Imaging System: From the Joint ACR/SNM/SCBT-MR PET-CT Working Group. J Am Coll Radiol, 2005;2:568-584.
  90. Massod Y, Liu YH, Depuey G, Taillefer R, Araujo L, Allen S, Delbeke D, Anstett F, Peretz A, Zito MJ, Tsatkin V, Wackers F. Clinical validation of attenuation correction using X-ray CT-derived attenuation maps. Multicenter trial with angiographic J Nucl Cardiol 2005;12(6):676-686.
  91. Machac J, Bacharach SL, Bateman TM, Bax J, Beanlands R, Bengel F,. Bergmann SR, Brunken RC, Case J, Delbeke D, DiCarli MF, Garcia EV,   Goldstein RA, Gropler RJ, Travin M, Patterson R, Schelbert HR. PET myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol 2006;13 (6):e121-151..
  92. Delbeke D (Chair), Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, Townsend DW, Berland LL, Parker JA, Hubner K, Stabin MJ, Zubal G, Kachelreiss M, Cronin V, Hoolbrook S. Society of Nuclear Medicine Procedure Guidelines for Tumor Imaging using FDG PET/CT. J Nucl Med 2006; 47 (5):885-895.
  93. Rhodes MM, Delbeke D, Whitlock JA, Martin WH, Kuttesch JF, Frangoul HA, Shankar S. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin’s and non-Hodgkin’s lymphoma. J Pediatr Hematol Oncol 2006;28:300-306.
  94. Delbeke D (Chair), Coleman RE, Guiberteau MJ, Brown ML, Royal HD, Siegel BA, Townsend DW, Berland LL, Parker JA, Hubner K, Stabin MJ, Zubal G, Kachelreiss M, Cronin V., Hoolbrook S. Society of Nuclear Medicine Procedure Guidelines for SPECT/CT imaging. J Nucl Med 2006; 47: 1227-1228.
  95. Conjoint Statement of the SNM and ACNP on credentialing and delineation of privileges for CT performed in conjunction with PET or SPECT. J Nucl Med 2006;47(9): 1561-1562.
  96. Conjoint Statement of the SNM and ACNP on credentialing and delineation of privileges for body PET. J Nucl Med 2006;47(9): 1559-1560.
  97. Conjoint Statement of the SNM and ACNP on credentialing and delineation of privileges for Cardiac PET. J Nucl Med 2007;48(5): 850-851.
  98. Conjoint Statement of the SNM and ACNP on credentialing and delineation of privileges for Cardiovascular CT. J Nucl Med 2007;48(5): 852-853.
  99. Malkerneker D, Brenner R, Martin WH, Sampson,UKA, Feurer I, Kronenberg MW, Delbeke D. CT-based attenuation correction versus prone imaging to decrease equivocal interpretations of rest/stress 99mTc-tetrafosmin SPECT MPI. J Nucl Cardiol 2007, 14:314-323.
  100. Podoloff DA, Advani RH, Allred C, Benson AB, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Grannis FW, Hillner BE, Hoffman JM, Keil K, Komaki R, Larson SM, Mankoff DA, Rozenzweig KE, Skibber JM, Yahalom J, Yu JM, Zelenetz AD. NCCN Task Force Report: Positron Emission Tomography (PET/Computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw 2007;May;5 Suppl 1: S1-S22.
  101. Krause BJ, Beyer T2, Delbeke D, Kotzerke J4, Minkov V5, Reiser M6 und der FDG- PET/CT in der Onkologie. Arbeitsausschuss Positronen-Emissions-Tomographie der Deutschen Gesellschaft für Nuklearmedizin 2007;46(6):291-301.
  102. Walker RC, Jones-Jackson LB, Martin WH, Habibian MR, Delbeke D. New imaging tools for the diagnosis of infection. Future Microbiol. 2007;2 (5): 527-554
  103. Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman JH, Coleman E, Wahl R, Paschold JC, Avril N, EinhornLH, Suh WW, Samson D, Delbeke D, Gorman M, Shields AF. Recommendations for the Use of FDG (fluorine-18, (2-[18F]Fluoro-2-deoxy-D-glucose) Positron Emission Tomography in Oncology. J Nucl Med 2008;49:480-508.
  104. Tan MC, Castaldo ET, Gao F, Chari RS, Linehan DC, Wright JK, Hawkins WG, Siegel BA, Delbeke D, Pinson CW, Strasberg SM.A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables .J Am Coll Surg. 2008 May;206(5):857-68; discussion 868-9. Epub 2008 Mar 17
  105. Dong C, Sriram S, Delbeke D, Al-Kaylani M, Arain AM, Singh P, McLean MJ, Abou-Khalil B. Aphasic or Amnesic Status Epilepticus Detected on PET but not EEG. Epilepsia 2009 Feb;50(2):251-5. Epub 2008 Sep 17.
  106. Schwartz JK, Dehdashti F, Grisby P, Delbeke D. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries. In Weber W (ed): Molecular Imaging of Cancer: From Molecules to Humans: Monitoring and Predicting Therapy Response with FDG PET. J Nucl Med 2009;50 Suppl 1: 64S-73S .
  107. Delbeke D, Schoder H, Martin WH, Wahl RW. Hybrid imaging (SPECT/CT and PET/CT)-improving therapeutic decisions. Semin Nucl Med 2009; Sept vol 39 (5):308-340.
  108. Podoloff DA, Ball DW, Ben-Josef E, Benson AB, Cohen SJ, Coleman RE, Delbeke D, Ho M, Ilson DH, Kalemkerian GP, Lee RJ, Loeffler JS, Macapinlac HA, Morgan RJ, Siegel BA, Singhal S, Tyler DS, Wong RJ. NCCN Task Force: Clinical Utility of PET in a Variety of Tumor Types Task Force. J Natl Compr Canc Netw 2009;7 Suppl 2: S1-S23.
  109. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler RJ, Knuuti J, Schelbert HR, Travin MI. P. ASNC guidelines for nuclear cardiology procedures: PET myocardial perfusion and metabolism clinical imaging. J Nucl Cardiol 2009; 16(4): 651. asnc.org
  110. Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti P. Expert opinions on imaging in lymphoma. The oncologist 2009 ; 14 Suppl 2 :30-40.
  111. Hachamovitch R, Johnson JR, Hlatky MA, Cantagallo L, Johnson BH, Coughlan M, Hainer J, Gierbolini J, Di Carli MF; SPARC Investigators. The study of myocardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and clinical outcomes. J Nucl Cardiol. 2009 Nov-Dec;16(6):935-48.
  112. Boellaard R, O’Doherty M, Weber W, Mottagny F, Lonsdale MN, Stroobants S, Hany T, Oyen WJG, Kotzerke J, Hoekstra OS, Pruim J, Marsden P, Tatsch K, HoekstraCJ, Visser E, Arends AJ, Verzijlbergen F, Zijlstra JM, Comans EFI, Lammertsma AA, Paans A, A.Willemsen A, Beyer T, Bockisch A, Schaefer C, Delbeke D, Baum RP, Chiti A, Krause BJ. FDG PET and PET/CT: EANM Procedure Guidelines for Tumour PET Imaging. Eur J Nucl Med Mol Imaging 2010; 37:181-200.
  113. Spratt DE, Diaz R, McElmurray J, Duggan D, Lu B, Delbeke D. Impact of FDG PET/CT on delineation of gross tumor volume (GTV) for radiation planning in non small cell lung cancer (NSCLC). Clin Nucl Med 2010;35 (4):237-243.
  114. Cerci JJ, Trindade E, Pracchia LF, Pitella FA, Linardi CC, Soares J Jr, Delbeke D, Topfer LA, Buccheri V, Meneghetti JC. Cost effectiveness of positron emission tomography in Hodgkin’s lymphoma patients in unconfirmed complete response or partial remission after first line therapy. J Clin Oncol 2010;28 (8):1415-21.
  115. Delbeke D and Martin WH. PET and PET/CT for pancreatic malignancies. Surg Oncol Clin N Am 2010; 19(2):235-254.
  116. Delbeke D. Addressing the short term while planning the long term. J Nucl Med 2010;51(7):18N.
  117. Cerci JJ, Pracchia LF, Linardi CC, Pitella FA, Delbeke D, Izaki M, Trindade E, Soares J Jr, Buccheri V, Meneghetti JC. 18F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin Lymphoma. J Nucl Med 2010;51(9):1337-1343.
  118. Delbeke D. Fulfilling a need for evidence-based medicine. J Nucl Med 2010;51 (9):39N.
  119. Delbeke D. Reaching out with radioimmunotherapy. J Nucl Med 2010;51 (11): 16N.
  120. Segall G, Delbeke D, Stabin MG, Even-Sapir E, Fair J, Sajdak R, Smith, G. SNM Practice Guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med 2010;51(11):1813-1820.
  121. Tulchinsky M, Ciak BW, Delbeke D, Hilson A, Holes-Lewis KA, Stabin MG. Ziessman HA. SNM Procedure Guideline for hepatobiliary scintigraphy 4.0. J Nucl Med 2010;38:210-218.
  122. Delbeke D. SNM general and hybrid guidelines. J Nucl Med 2010;51 (12): 14N.
  123. Delbeke D, Graham M, Royal H, Segall G, Shulkin BL, Ziessman HA; Accreditation Council of Graduate Medical Education; American College of Nuclear Medicine; American Board of Nuclear Medicine. Conjoint statement of the SNM, ACNM, and ABNM on credentialing and delineation of privileges for therapeutic [procedures using radiopharmaceuticals. J Nucl Med. 2011 Feb;52(2):323-6.
  124. Delbeke D, Martin WH. FDG PET and PET/CT for colorectal cancer. Methods Mol Biol 2011;727:77-103.
  125. Delbeke D, Segall GM. We can’t control the future but we can plan for it. J Nucl Med 2011; 52 (3): 24N.
  126. Delbeke D. A President’s farewell message. J Nucl Med 2011;52 (6): 24N-25N.
  127. Cardiovascular Council Board of Directors. Cardiovascular nuclear imaging: Balancing proven clinical value and potential radiation risk. J Nucl Med. 2011 Jul;52(7):1162-4.
  128. Cerci JJ; Trindade E; Buccheri V; Fanti S; Coutinho AMN; Zanoni L; Linardi CCG; Celli M; Delbeke D; Pracchia LF; Pitela FA; Soares J; Zinzani PL; Meneghetti JC. Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across juridictions. Clinical Lymphoma, Myeloma & Leukemia 2011;11 (4): 314-320.
  129. Cerci MS, Cerci JJ, Cerci RJ, Pereira Neto CC, Trindade E, Delbeke D, da Cunha CL, Vitola JV. Myocardial perfusion imaging is a strong predictor of death in women. JACC Cardiovasc Imaging. 2011 Aug;4(8):314-320.
  130. Balon HR, Brown TL, Goldsmith SJ, Silberstein EB, Krenning EP, Lang O, Dillehay G, Tarrance J, Johnson M, Stabin MG; Society of Nuclear Medicine. The SNM practice guideline for somatostatin receptor scintigraphy 2.0. J Nucl Med Technol. 2011 Dec;39(4):317-24.
  131. Delbeke D, Dillehay GL, Segall GM, Hillman BJ. MITA PET Coverage Workshop. J Nucl Med. 2011 Dec;52(12):27N.
  132. Hillman BJ, Frank RA, Rodriguez GM; Medical Imaging & Technology Alliance (MITA) Workshop participants. New pathways to medicare coverage for innovative PET radiopharmaceuticals: report of a medical imaging & technology alliance (MITA) workshop. J Nucl Med. 2012 Feb;53(2):336-42.
  133. Hillman BJ, Frank RA, Rodriguez GM; Medical Imaging & Technology Alliance (MITA) Workshop participants. New pathways to medicare coverage for innovative PET radiopharmaceuticals: report of a medical imaging & technology alliance (MITA) workshop. J Am Coll Radiol. 2012 Feb;9(2):108-14.Hachamovitch R, Nutter B, Hlatky MA, Shaw LJ, Ridner ML, Dorbala S, Beanlands RS, Chow BJ, Branscomb E, Chareonthaitawee P, Weigold WG, Voros S, Abbara S, Yasuda T, Jacobs JE, Lesser J, Berman DS, Thomson LE, Raman S, Heller GV, Schussheim A, Brunken R, Williams KA, Farkas S, Delbeke D, Schoepf UJ, Reichek N, Rabinowitz S, Sigman SR, Patterson R, Corn CR, White R, Kazerooni E, Corbett J, Bokhari S, Machac J, Guarneri E, Borges-Neto S, Millstine JW, Caldwell J, Arrighi J, Hoffmann U, Budoff M, Lima J, Johnson JR, Johnson B, Gaber M, Williams JA, Foster C, Hainer J, Di Carli MF; SPARC Investigators. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).J Am Coll Cardiol. 2012 Jan 31;59(5):462-74.
  134. Delbeke, Segall GM. Status and Trends in Nuclear Medicine in the United States. J Nucl Med 2011;52 (Suppl 2): 24S-29S.
  135. Parker JA, Coleman RE, Grady E, Royal HD, Siegel BA, Stabin MG, Sostman HD, Hilson AJ; Society of Nuclear Medicine. SNM practice guideline for lung scintigraphy 4.0. J Nucl Med Technol. 2012 Mar;40(1):57-65.
  136. Delbeke D. Update on guidelines. J Nucl Med 2012;53:13N.
  137. Delbeke D. Letter to the editor: Integrated residency training pathways of the future: Diagnostic radiology, nuclear radiology, nuclear medicine, and molecular imaging. J Am Coll Radiol 2012;9:372-373.
  138. Delbeke D, Chiti A, Christian P, Darcourt J, Donohoe K, Flotats A, Krause BJ, Royal HD. SNM/EANM guideline for guideline development 6.0 J Nucl Med Technol. Dec 2012
  139. Delbeke D, Royal HD; Graham MM; Segall GM. SNM/ABNM joint statement on optimizing training in nuclear medicine in the era of multimodality and hybrid imaging. J Nucl Med 2012;53: 1490-1495.
  140. Li X, Abramson RG, Arlinghaus LR, Chakravarthy AB, Abramson V, Mayer I, Farley J, Delbeke D, Yankeelov TE. An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results. EJNMMI Res. 2012 Nov 16;2(1):62.
  141. Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, Israel O, Martin-Comin J, Signore A. EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection. J Nucl Med. 2013;54:647-658.
  142. Delbeke D. Learning: The JNM editorial process. J Nucl Med 2013;54 (3):27A-28A.
  143. Delbeke D, Graham MM. The Joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumors. J Nucl Med 2013;54 (5):663.
  144. Delbeke D. Alessio A, Iagaru A. Second sino-american conference in nuclear medicine. J Nucl Med 2013;54:15N-16N.
  145. Dorbala S, Di Carli MF, Delbeke D, Abara S, DePuey EG, Dilsizian V, Forrester J, Janowitz W, Kauffman PA, Mahmarian J, Moore SC, Stabin MG, Shreve P. SNMMI/ASNC/SCCT Guideline for cardiac SPECT/CT and PET/CT. J Nucl Med 2013;54: 1485-507.
  146. Delbeke D, Graham MM. Addendum to the editorial “Joint guidance on peptide receptor radionuclide therapy in neuroendocrine tumors”. J Nucl Med. 2013 Jul;54(7):1170.
  147. Cerci JJ, Linardi CC, Pracchia LF, Junior JS, Trindade E, Delbeke D, Cerci RJ, Carr R, Meneghetti JC, Buccheri V. 3. 2-[18F]-fluoro-2-desoxy-D-glucose positron emission tomography initial staging impacts on survival in Hodgkin lymphoma. World J Radiol. 2013 Dec 28;5(12):484-90.
  148. Delbeke D. Open access. J. Nucl. Med 2014;55:22A.
  149. Spottswood SE, Pfluger T, Bartold SP, Brandon D, Burchell N, Delbeke D, Fink-Bennett DM, Hodges PK, Jolles PR, Lassmann M, Maurer AH, Seabold JE, Stabin MG, Treves ST, Vlajkovic M. SNMMI and EANM Practice Guideline for Meckel Diverticulum Scintigraphy 2.0. J Nucl Med Technol. 2014 Jun 19.
  150. Delbeke D. Commentary on “Somatostatin Receptor Imaging with Ga-68 DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls and Pitfalls in Interpretation. Radiographics 2015; March-April: in press

Books

  1. Jeanty P, Delbeke D, Payne F. Louisville Trivia. Iatroglyph, First Edition: 1988. Second Edition: 1989.
  2. Habibian MR, Delbeke D, Martin WH, Sandler MP (eds): Nuclear Medicine Imaging: A Teaching File. Williams & Wilkins, Baltimore, MD, 1999.
  3. Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002.
  4. Vitola JV and Delbeke D (eds): Nuclear Cardiology and Correlative Imaging: A Teaching File. Springer-Verlag, NY, 2004.
  5. Valk PE, Delbeke D, Bailey DL, Townsend DW, Maisey MN (eds) Positron Emission Tomography: Clinical Practice. Springer-Verlag, London, UK, 2006.
  6. Habibian MR, Delbeke D, Martin WH, Sandler MP (eds): Nuclear Medicine Imaging: A Teaching File. Williams & Wilkins, Baltimore, MD, 2008, Second edition.
  7. Delbeke D and Israel O (eds): Hybrid PET/CT and SPECT/CT Imaging: A teaching file. Springer Verlag, New York, NY, 2010.
  8. Cerci, J, Fanti, S and Delbeke D (eds): Oncological PET/CT with Histological Confirmation. Springer Verlag, New York, NY (in preparation).

Chapters and Review Articles

  1. Delbeke D, Carroll FE, Sandler MP. Pulmonary imaging. In Sandler MP, Patton JA, Shaff MI, Powers TA, and Partain CL (eds): “Correlative Imaging: Nuclear Medicine, Magnetic Resonance, Computed Tomography, Ultrasound”. Williams & Wilkins, Baltimore, MD 1989, pp 325-359.
  2. Delbeke D, Clanton JA. Radiopharmaceuticals. In Sandler MP, Patton JA, Shaff MI, Powers TA, and Partain CL (eds): “Correlative Imaging: Nuclear Medicine, Magnetic Resonance, Computed Tomography, and Ultrasound”. Williams & Wilkins, Baltimore, MD 1989, pp 63-92.
  3. Delbeke D, Clanton JA. Radiopharmaceuticals. In Sandler MP, Patton JA, Gross MD et al (eds): “Endocrine Imaging”. Appleton & Lange, Norwalk, 1991, pp 93-109.
  4. Sandler MP, Delbeke D. Radionuclides in endocrine imaging. The Radiologic Clinics of North America. W.B. Saunders Company, Philadelphia, PA, 1999;31(4).
  5. Delbeke D, Sandler MP. Heart and Lung Transplantation. In Sandler MP, Coleman RD, Wackers JTH, Patton JA, Gottschalk A, Hoffer PB (eds): “Diagnostic Nuclear Medicine,” 3rd ed. Williams & Wilkins, Baltimore, MD, 1996, pp 1345-1360.
  6. Gelfand M, Delbeke D, Lawrence SK. Pediatric Brain Imaging. In Sandler MP, Coleman RD, Wackers JTH, Patton JA, Gottschalk A, Hoffer PB (eds): “Diagnostic Nuclear Medicine,” 3rd ed. Williams & Wilkins, Baltimore, MD, 1996, pp 1465-1492.
  7. Delbeke D, Patton JA, Martin WH, Sandler MP. Positron imaging in oncology: Present and future. In Freeman L (ed): “Nuclear Medicine Annual”. Williams & Wilkins, Baltimore, MD, 1998, pp 1-49.
  8. Delbeke D. Neurologic In Habibian MR, Delbeke D, Martin WH, Sandler MP (eds): Nuclear Medicine Imaging: A Teaching File. Williams & Wilkins, Baltimore, MD, 1999, pp217-272.
  9. Bazarjani S, Delbeke D. Renal Scintigraphy. In Habibian MR, Delbeke D, Martin WH, Sandler MP (eds): Nuclear Medicine Imaging: A Teaching File. Williams & Wilkins, Baltimore, MD, 1999, pp365-434.
  10. Martin WH, Delbeke D. Oncologic Imaging. In Habibian MR, Delbeke D, Martin WH, Sandler MP (eds): Nuclear Medicine Imaging: A Teaching File. Williams & Wilkins, Baltimore, MD, 1999, pp 619-722.
  11. Passalaqua S, Delbeke D. Pediatric Nuclear Imaging. In Habibian MR, Delbeke D, Martin WH, Sandler MP (eds): Nuclear Medicine Imaging: A Teaching File. Williams & Wilkins, Baltimore, MD, 1999, pp785-850.
  12. Kuwert T, Delbeke D. Brain Tumors. In Wieler HJ and Coleman ED (eds): PET in clinical oncology. Springer Steinkopff Verlag,Darmstadt 2000, pp 125-133.
  13. Delbeke D , Valk P. PET-Diagnosis and Management of Colorectal Carcinoma. In Khalkhali I, Maublant J, Goldsmith SJ, (eds): Nuclear Oncology: Diagnosis & Therapy. Williams & Wilkins, Baltimore, MD, 2001, pp 351-361.
  14. Delbeke D. PET oncologic imaging. In Ziesmann H (ed): The Radiologic Clinics of North America: Update in Nuclear Medicine. W.B. Saunders Company, Philadelphia, PA, 2001;39:883-917.
  15. Delbeke D. Clinical applications for the central nervous system. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002.
  16. Grigolon MV, Delbeke D. Clinical Applications in Oncology: Normal distribution of FDG. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002..
  17. Hopper OW, Martin WH, Delbeke D. Clinical Applications in Oncology: Head and Neck Carcinoma. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002.
  18. Kuzucu M, Martin WH, Delbeke D. Clinical Applications in Oncology: Lung Tumors. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002.
  19. Simmons-Stokes L, Martin WH, Delbeke D. Clinical Applications in Oncology: Breast Carcinoma. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002.
  20. Delbeke D, Martin WH. Clinical Applications in Oncology: Colorectal Carcinoma. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002.
  21. Johnson D, Martin WH, Delbeke D. Clinical Applications in Oncology: Other Gastrointestinal Tumors. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002, pp236-279..
  22. Martin WH, Delbeke D. Clinical Applications in Oncology: Genitourinary Tract. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002.
  23. Martin WH, Gibson A, Delbeke D. Clinical Applications in Oncology: Lymphoma. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002.
  24. Pope S, Martin WH, Delbeke D. Clinical Applications in Oncology: Melanoma. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002.
  25. Martin WH, Delbeke D. Clinical Applications in Oncology: Miscellaneous Body Tumors. In Delbeke D, Martin WH, Patton JA, Sandler MP (eds): Practical FDG Imaging: A teaching file. Springer Verlag, New York, NY, 2002.
  26. Bax JJ, Delbeke D, Vitola JV, Poldermans D, Elhendy A, Boersma E, van der Wall EE, Sandler MP. Heart and Lung Transplantation. In Sandler MP, Coleman RD, Wackers JTH, Patton JA, Gottschalk A, Hoffer PB (eds): “Diagnostic Nuclear Medicine,” 4rd ed. Williams & Wilkins, Baltimore, MD, 2003, pp 1051-1071.
  27. Gelfand M, Delbeke D, Lawrence SK. Pediatric Brain Imaging. In Sandler MP, Coleman RD, Wackers JTH, Patton JA, Gottschalk A, Hoffer PB (eds): “Diagnostic Nuclear Medicine,” 3rd ed. Williams & Wilkins, Baltimore, MD, 2003, pp 1179-1203.
  28. Lawrence SK, Delbeke D, Partain CL, Sandler MP. Cerebrospinal Fluid Imaging. In Sandler MP, Coleman RD, Wackers JTH, Patton JA, Gottschalk A, Hoffer PB (eds): “Diagnostic Nuclear Medicine,” 4rd ed. Williams & Wilkins, Baltimore, MD, 2003, pp 835-849.
  29. Lowe V, Delbeke D, Coleman RE. Applications of PET in oncologic imaging. In Sandler MP, Coleman RD, Wackers JTH, Patton JA, Gottschalk A, Hoffer PB (eds): “Diagnostic Nuclear Medicine,” 4rd ed. Williams & Wilkins, Baltimore, MD, 2003, pp 987-1013.
  30. Delbeke D, Martin WH, Sandler MP. Applications for FDG PET imaging in the evaluation of patients with colorectal carcinoma, hepatobiliary malignancies and cancer of the pancreas. In Wahl RL (ed) Principles and Practices of Positron Emission Tomography. Lippincottt Williams & Wilkins, Baltimore, MD, 2002, pp 17-233
  31. Martin WH. PET imaging in tumors of the pancreas and the liver. In Valk PE, Bailey DL, Townsend DW, Maisey MN (eds) Positron Emission Tomography: Basic Sciences and Clinical Practice. Springer-Verlag, London, UK. 2003;583-595.
  32. Delbeke D, Patton JA. Correlation of PET and CT in clinical management. In DeVita VT, Hellman S and Rosenberg SA (eds): Progress in Oncology 2003. Jones and Barlett, Boston, MA, 2003;pp231-249.
  33. Delbeke D. PET-CT in Oncology. In Discussions in PET Imaging Newsletter from Diagnostic Imaging. 2003 CMP Healthcare Media, DPI #623.
  34. Delbeke D. Pancreatic cancer. In Oehr P. et al (eds): PET and PET-CT in Oncology. Springer-Verlag, Heidelberg, Germany, 2003.
  35. Vitola JV, Delbeke D. Diagnostic tools to approach the cardiac patient. In Vitola JV and Delbeke D (eds): Nuclear Cardiology and Correlative Imaging: A Teaching File, Springer Verlag, New York, NY 2004; 1-12.
  36. Delbeke D, Vitola JV, Martin WH. Radiopharmaceuticals and Protocols in Nuclear Cardiology. In Vitola JV and Delbeke D (eds): Nuclear Cardiology and Correlative Imaging: A Teaching File, Springer Verlag, New York, NY 2004, 49-83 .
  37. Vitola JV, Lafitte Stier A, Kormann OJ, Delbeke D. Stress modalities to evaluate myocardial perfusion. In Vitola JV and Delbeke D (eds): Nuclear Cardiology and Correlative Imaging: A Teaching File, Springer Verlag, New York, NY 2004; 84-120.
  38. Vitola JV, Delbeke D, Smith AC, Cunha Pereira Neto C, Martin WH, Habibian MR. Myocardial perfusion imaging for the detection of ischemia. In Vitola JV and Delbeke D (eds): Nuclear Cardiology and Correlative Imaging: A Teaching File, Springer Verlag, New York, NY 2004, 121-146.
  39. Ribeiro France Neto O, Delbeke D, Vitola JV, Ziffer JA. Myocardial perfusion in the emergency room. In Vitola JV and Delbeke D (eds): Nuclear Cardiology and Correlative Imaging: A Teaching File, Springer Verlag, New York, NY 2004; 155-157.
  40. Delbeke D, Bax JJ, Martin WH, Sandler MP. Evaluation of myocardial viability. In Vitola JV and Delbeke D (eds): Nuclear Cardiology and Correlative Imaging: A Teaching File, Springer Verlag, New York, NY 2004; 205-252.
  41. Shaw LS, Heller GV, Schwartz R, Cunha Pereira C, Ludwig V, Vitola JV, Delbeke D, Berman Nuclear Cardiology for Imaging the Effects of Therapy. In Vitola JV and Delbeke D (eds): Nuclear Cardiology and Correlative Imaging: A Teaching File, Springer Verlag, New York, NY 2004, 279-308.
  42. Vitola JV, Matthias W, Meneghetti JC, Delbeke D. Correlation of Nuclear Imaging with In Vitola JV and Delbeke D (eds): Nuclear Cardiology and Correlative Imaging: A Teaching File, Springer Verlag, New York, NY 2004; 406-423.
  43. Delbeke D, Schindler T, Townsend D, Kaufman P, vonSchulthess GK, Schelbert H. Advance Cardiac Applications for PET and PET/CT. In Vitola JV and Delbeke D (eds): Nuclear Cardiology and Correlative Imaging: A Teaching File, Springer Verlag, New York, NY 2004; 424-443.
  44. Delbeke D. PET and PET/CT for colorectal cancer. In Discussions in PET Imaging Newsletter from Diagnostic Imaging. 2003 CMP Healthcare Media, November 2004.
  45. Vitola JV, Mastrocolla LE, Delbeke D. Procedimientos de estrés farmacológico en cardiologia nuclear. In Cardiología Nuclear y otras técnicas no invasivas de imagen en cardiología. Editor JM Castro-Beiras, first edition, Meditecnica, pp 249-258, Madrid, Spain, 2005.
  46. Delbeke D, Martin WH. PET imaging in tumors of the pancreas and the liver. In Valk PE, Delbeke D, Bailey DL, Townsend DW, Maisey MN (eds) Positron Emission Tomography: Clinical Practice. Springer-Verlag, London, UK. 2006 pp181-196.
  47. Delbeke D, Martin WH. Incremental value of imaging structure and function. In Valk PE, Delbeke D, Bailey DL, Townsend DW, Maisey MN (eds) Positron Emission Tomography: Clinical Practice. Springer-Verlag, London, UK. 2006, pp 17-26.
  48. Martin WH, Delbeke D. 131I-SPECT/CT for thyroid cancer imaging. In Golsdmith S and Israel O (eds) Hybrid SPECT/CT Tumor Imaging. Marcel Dekker, Inc. 2006.
  49. Delbeke D. SNM LLSAP Module 1 on Oncology PET and PET/CT : Gastrointestinal malignancies. SNM website 2006. http://interactive.snm.org/index.cfm?PageID=4558&RPID=4037
  50. Delbeke D. SNM LLSAP Module 5 on Cardiovascular CT. SNM website 2006. http://interactive.snm.org/index.cfm?PageID=4558&RPID=4037
  51. James McCarley, Ronald Walker, Lavanya Kalla, Laurie Jones-Jackson, Twyla Bartel, Victoria Major, MD, Hemendra Shah, Dominique Delbeke. SNM LLSAP Module 2 on Oncology CT : CT abdomen. SNM website 2006. http://interactive.snm.org/index.cfm?PageID=4558&RPID=4037
  52. Leah Braswell, Ronald Walker, Lavanya Kalla, Laurie Jones-Jackson, Twyla Bartel, DO, Victoria Major, Hemendra Shah, Dominique Delbeke. SNM LLSAP Module 2 on Oncology CT : CT pelvis. SNM website 2006. http://interactive.snm.org/index.cfm?PageID=4558&RPID=4037
  53. Delbeke D. SPECT or PET/CT detects stenosis and ischemia in a single exam. Diagnostic Imaging 2007; Nov.
  54. Delbeke D, Martin WH, Sandler MP. Applications for FDG PET and PET/CT imaging in the evaluation of patients with colorectal carcinoma. In Wahl RL (ed) Principles and Practices of Positron Emission Tomography. Lippincottt Williams & Wilkins, Baltimore, MD, 2009, pp 320-331.
  55. Oleg Teytelboym, Delbeke D, Wahl RL. Pancreatic and hepatobiliary cancers.. In Wahl RL (ed) Principles and Practices of Positron Emission Tomography. Lippincottt Williams & Wilkins, Baltimore, MD, 2009, pp 331-348.
  56. Delbeke D, Carlos Cunha. Neurologic In Habibian MR, Delbeke D, Martin WH, Sandler MP (eds): Nuclear Medicine Imaging: A Teaching File. Williams & Wilkins, Baltimore, MD, 2008, pp.
  57. Bazarjani S, Carlos Cunha, Delbeke D. Renal Scintigraphy. In Habibian MR, Delbeke D, Martin WH, Sandler MP (eds): Nuclear Medicine Imaging: A Teaching File. Williams & Wilkins, Baltimore, MD, 2008, pp.
  58. Delbeke D, Martin WH. Oncologic Imaging. In Habibian MR, Delbeke D, Martin WH, Sandler MP (eds): Nuclear Medicine Imaging: A Teaching File. Williams & Wilkins, Baltimore, MD, 2008, pp .
    Vitola JV, Delbeke D. Cardiac Imaging. In Habibian MR, Delbeke D, Martin WH, Sandler MP (eds): Nuclear Medicine Imaging: A Teaching File. Williams & Wilkins, Baltimore, MD, 2008, pp .
  59. Delbeke D, Walker R. Colorectal cancer. In Delbeke D and Israel O (eds): Hybrid PET/CT and SPECT/CT Imaging: A teaching file. Springer Verlag, New York, NY, 2009.
  60. Delbeke D, Walker R. Hepatobiliary and Pancreatic Malignancies. In Delbeke D and Israel O (eds): Hybrid PET/CT and SPECT/CT Imaging: A teaching file. Springer Verlag, New York, NY, 2009.
  61. Walker R, Jones-Jackson L, Delbeke D. Lung cancer. In Delbeke D and Israel O (eds): Hybrid PET/CT and SPECT/CT Imaging: A teaching file. Springer Verlag, New York, NY, 2009.
  62. Walker R, Jones-Jackson L, Delbeke D. Melanoma. In Delbeke D and Israel O (eds): Hybrid PET/CT and SPECT/CT Imaging: A teaching file. Springer Verlag, New York, NY, 2009.
  63. Jessop A, Walker R, Delbeke D. Brain cancer. In Delbeke D and Israel O (eds): Hybrid PET/CT and SPECT/CT Imaging: A teaching file. Springer Verlag, New York, NY, 2009.
  64. Israel O, Delbeke D. Physiological distribution of radiopharmaceuticals. In Delbeke D and Israel O (eds): Hybrid PET/CT and SPECT/CT Imaging: A teaching file. Springer Verlag, New York, NY, 2009.
  65. Delbeke D and Martin WH. PET and PET/CT for pancreatic malignancies. In Hustinx R (ed): PET Clinic Series on Gastrointestinal Malignancies. Elsevier 2009.
  66. Delbeke D and Martin WH. FDG PET and PET/CT for colorectal cancer. In Hoekstra O and Juweid M (eds): Positron Emission Tomography: Methods in Molecular Biology. Humana Press, New Jersey 2011, vol 727 pp 77-103.
  67. Delbeke D, Bischof Delaloye A, Conti P. Functional Imaging in Lymphoma Diagnosis and   Staging. In Macklis R and Conti PS (eds): Image-Guided Radiation Therapy in Lymphoma Management The Increasing Role of Functional Imaging. Informa UK, London, UK 2010.
  68. Jessop AC, Delbeke D. Pancreas and Liver (Chapter 10). In Gerbaudo VH (ed): A Case-Based Approach to PET/CT in Oncology. Cambridge University Press, 2012
  69. Jones-Jackson LB, Walker RC, Delbeke D. Liver metastases from colorectal cancers. In: Keiding S, Sørensen S, eds. Functional and Molecular Imaging in Hepatology. Sharjah,   UAE: Bentham Science Publishers; 2014:104–119.